J L Naylor - JoVE Visualize

Showing results (1-10 of 8) with videos related to

Pageof 1

Sort By:

Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1995

Identification and quantification of fluorine-containing metabolites of 1-chloro-2,2,2-trifluoroethane (HCFC133A) in the rat by 19F-NMR spectroscopyM K Ellis, J L Naylor, T Green, et al.

Human & Experimental Toxicology|July 1, 1996

Metabolism and disposition of difluoromethane (HFC32) in the mouseM K Ellis, J L Naylor, M A Collins, et al.

The American Journal of Digestive Diseases|October 1, 1977

Relative concentrations of individual nonsulfated bile acids in the serum and bile of patients with cirrhosisJ E Struthers, S J Mehta, M D Kaye, et al.

Biochimica Et Biophysica Acta|April 25, 1984

Relationships between the chemical constitution of aggregation inhibitors and human blood platelet response profileA Lasslo, R P Quintana, R W Johnson, et al.

Human & Experimental Toxicology|July 1, 1995

Further evidence that the blood/brain barrier impedes paraquat entry into the brainJ L Naylor, P S Widdowson, M G Simpson, et al.

Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|June 1, 1996

The inhalation toxicology, genetic toxicology, and metabolism of difluoromethane in the ratM K Ellis, R Trebilcock, J L Naylor, et al.

International Journal of Circumpolar Health|February 18, 2004

Diabetes among Alaska Natives: a reviewJ L Naylor, C D Schraer, A M Mayer, et al.

Medical Progress Through Technology|January 1, 1986

Interrelationships between the chemical structure of synthetic entities, their platelet aggregation inhibitory potency and their cellular toxicity, based on in vitro experimentsA Lasslo, E O Dillingham, J C McCastlain, et al.

Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:

Pageof 1

Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 1, 1995

Identification and quantification of fluorine-containing metabolites of 1-chloro-2,2,2-trifluoroethane (HCFC133A) in the rat by 19F-NMR spectroscopyM K Ellis, J L Naylor, T Green, et al.

Human & Experimental Toxicology|July 1, 1996

Metabolism and disposition of difluoromethane (HFC32) in the mouseM K Ellis, J L Naylor, M A Collins, et al.

The American Journal of Digestive Diseases|October 1, 1977

Relative concentrations of individual nonsulfated bile acids in the serum and bile of patients with cirrhosisJ E Struthers, S J Mehta, M D Kaye, et al.

Biochimica Et Biophysica Acta|April 25, 1984

Relationships between the chemical constitution of aggregation inhibitors and human blood platelet response profileA Lasslo, R P Quintana, R W Johnson, et al.

Human & Experimental Toxicology|July 1, 1995

Further evidence that the blood/brain barrier impedes paraquat entry into the brainJ L Naylor, P S Widdowson, M G Simpson, et al.

Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|June 1, 1996

The inhalation toxicology, genetic toxicology, and metabolism of difluoromethane in the ratM K Ellis, R Trebilcock, J L Naylor, et al.

International Journal of Circumpolar Health|February 18, 2004

Diabetes among Alaska Natives: a reviewJ L Naylor, C D Schraer, A M Mayer, et al.

Medical Progress Through Technology|January 1, 1986

Interrelationships between the chemical structure of synthetic entities, their platelet aggregation inhibitory potency and their cellular toxicity, based on in vitro experimentsA Lasslo, E O Dillingham, J C McCastlain, et al.

Pageof 1